期刊文献+

成本-效果阈值在医保准入决策中的应用 被引量:5

The Application of Cost-effectiveness Threshold in Medical Insurance Access Decision-making
原文传递
导出
摘要 随着医疗保险药品谈判及目录动态调整工作的推进,我国医疗保险准入决策机制得到不断完善。现从经济学审评角度出发,深入研究成本-效果阈值的设置、调整方法,及其医疗保险准入决策中的应用模式,旨在基于域外典型应用经验为我国成本-效果阈值在医疗保险准入决策中的应用方案提供可行性建议,进一步完善我国医疗保险准入决策体系。 With the advancement of medical insurance drug negotiations and medical insurance directory dynamic adjustment, China’s medical insurance access decision-making mechanism has been continuously improved. From the perspective of economic evaluation, this paper deeply studies the setting and adjustment methods of cost-effectiveness threshold and the application modes in medical insurance access decision-making, to provide feasible suggestions for China’s application of cost-effectiveness threshold in access decision-making of medical insurance system based on the typical foreign application experience, and to further improve the reimbursement decision-making of medical insurance system.
作者 李轶 LI Yi(China Pharmaceutical University,Nanjing 211198,China)
机构地区 中国药科大学
出处 《中国药物经济学》 2020年第9期30-35,共6页 China Journal of Pharmaceutical Economics
关键词 成本-效果阈值 医疗保险准入 决策 Cost-effectiveness threshold Medical insurance access Decision making
  • 相关文献

参考文献1

二级参考文献3

共引文献10

同被引文献64

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部